STOCK TITAN

Ardent Health (NYSE: ARDT) ex-exec lines up six-figure stock sale

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Ardent Health, Inc. (ARDT) is the issuer for a Rule 144 notice covering planned sales of common stock held for the account of former officer and director Martin Bonick. The filing lists up to 35,930 shares of common stock, with an aggregate market value of $377,363.99, proposed for sale on 08/20/2026 through Fidelity Brokerage Services LLC on the NYSE. It also notes that the shares to be sold include restricted stock vesting events of 8,994 shares on 03/31/2026 and 26,936 shares on 04/01/2026, received from the issuer as compensation, and discloses a prior sale of 35,930 shares on 08/18/2026 for $393,481.70.

Positive

  • None.

Negative

  • None.
Shares proposed to be sold 35,930 shares Common stock proposed for sale on 08/20/2026 under Rule 144
Aggregate market value of proposed sale $377,363.99 Value of 35,930 shares of common stock covered by the notice
Shares sold in past 3 months 35,930 shares Common stock sold on 08/18/2026 by or for Martin Bonick
Proceeds from past 3 months sale $393,481.70 Total proceeds from 35,930 shares sold on 08/18/2026
Restricted stock vesting 03/31/2026 8,994 shares Restricted stock vesting from issuer as compensation
Restricted stock vesting 04/01/2026 26,936 shares Restricted stock vesting from issuer as compensation
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Common | 03/31/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Aggregate Market Value financial
"35930 | 377363.99 | 141045907 | 08/20/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
attorney-in-fact regulatory
"as attorney-in-fact for Martin Bonick"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does this Form 144 filing mean for Ardent Health, Inc. (ARDT)?

The filing reports a planned sale under Rule 144 of Ardent Health, Inc. common stock held for former officer and director Martin Bonick. It is a disclosure of potential secondary market sales and does not describe any new issuance of shares by the company.

How many ARDT shares are covered by Martin Bonick’s planned Rule 144 sale?

The notice covers up to 35,930 shares of Ardent Health, Inc. common stock, with an aggregate market value of $377,363.99, proposed for sale on 08/20/2026 through Fidelity Brokerage Services LLC on the NYSE.

What prior ARDT stock sales by Martin Bonick are disclosed in this Form 144?

The filing discloses that on 08/18/2026, 35,930 shares of Ardent Health, Inc. common stock were sold for total proceeds of $393,481.70. This relates to the requirement to report securities sold during the past three months.

What is the source of the Ardent Health (ARDT) shares to be sold under this notice?

The shares come from restricted stock vesting granted by the issuer as compensation: 8,994 shares vesting on 03/31/2026 and 26,936 shares vesting on 04/01/2026, both listed as compensation from Ardent Health, Inc.

Who is executing the planned sale of ARDT shares for Martin Bonick?

The planned sale of up to 35,930 shares of Ardent Health, Inc. common stock is to be executed through Fidelity Brokerage Services LLC. The Form 144 is signed by Jared Cook as a duly authorized representative and attorney-in-fact for Martin Bonick.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature